natgillin/translations-raw huggingface dataset:
I, the undersigned official veterinarian, declare that I have read and understood Regulation (EC) No 1069/2009 of the European Parliament and of the Council ( 1a ) and Commission Regulation (EU) No 142/2011 ( 1b ) and certify that the blood products described above:
so bili pripravljeni in skladiščeni v objektu, ki ga je odobril in validiral ter ga nadzoruje pristojni organ v skladu s členom 24 Uredbe (ES) št. 1069/2009;
consist of blood products that satisfy the health requirements below;
so bili pripravljeni izključno iz naslednjih živalskih stranskih proizvodov:
consist exclusively of blood products not intended for human consumption;
( 2 ) bodisi [krvi zaklanih živali, ki so bile ocenjene kot ustrezne za prehrano ljudi v skladu z zakonodajo Unije, vendar niso namenjene za prehrano ljudi iz komercialnih razlogov;]
have been prepared and stored in a plant, approved, validated and supervised by the competent authority in accordance with Article 24 of Regulation (EC) No 1069/2009;
( 2 ) in/ali [krvi zaklanih živali, ki so bile ocenjene kot neustrezne za prehrano ljudi v skladu z zakonodajo Unije, vendar niso kazale nobenih znakov bolezni, prenosljivih na ljudi ali živali, iz trupov, ki so bili zaklani v klavnici in so bili ocenjeni kot ustrezni za prehrano ljudi na podlagi pregleda pred zakolom v skladu z zakonodajo Unije;]
have been prepared exclusively with the following animal by-products:
so bili za inaktivacijo patogenov
( 2 ) either [blood of slaughtered animals, which is fit for human consumption in accordance with Union legislation, but is not intended for human consumption for commercial reasons;]
( 2 ) bodisi [predelani v skladu z metodo predelave ( 3 ) iz poglavja III Priloge IV k Uredbi (EU) št. 142/2011;]
( 2 ) and/or [blood of slaughtered animals, which is rejected as unfit for human consumption in accordance with Union legislation, but which did not show any signs of diseases communicable to humans or animals, derived from carcases that have been slaughtered in a slaughterhouse and were considered fit for human consumption following an ante-mortem inspection in accordance with Union legislation;]
( 2 ) ali [obdelani po metodi in pri parametrih, ki zagotavljajo skladnost proizvoda z mikrobiološkimi standardi iz poglavja I Priloge X k Uredbi (EU) št. 142/2011;]
in order to inactivate pathogenic agents, have been submitted
( 2 ) ali [v primeru krvnih proizvodov, vključno z razprševanjem posušeno krvjo in krvno plazmo, prašičjega izvora, namenjenih za krmljenje prašičev, toplotno obdelani pri temperaturi najmanj 80 °C, enakomerno razporejeni po vsej snovi, suha kri in krvna plazma pa ne vsebujeta več kot 8 % vlage z aktivnostjo vode (Aw) manj kot 0,60;]
( 2 ) either [to processing in accordance with processing method ( 3 ) as set out in Chapter III of Annex IV to Regulation (EU) No 142/2011;]
jih je pregledal pristojni organ z odvzemom naključnega vzorca neposredno pred odpremo in ugotovil, da je skladen z naslednjimi standardi ( 4 ):
( 2 ) or [to a method and parameters which ensure that the product complies with the microbiological standards set in Chapter I of Annex X to Regulation (EU) No 142/2011;]
Salmonella : odsotnost v 25 g: n = 5, c = 0, m = 0, M = 0,
( 2 ) or [in the case of blood products, including spray dried blood and blood plasma, of porcine origin intended for the feeding of porcine animals, to a heat treatment at a temperature of at least 80°C throughout the substance and the dry blood and blood plasma is of not more than 8% moisture with a water activity (Aw) of less than 0,60.]
Enterobacteriaceae : n = 5, c = 2, m = 10, M = 300 v 1 gramu;
have been examined under the responsibility of the competent authority taking a random sample immediately prior to dispatch and found it to comply with the following standards ( 4 ):
končni proizvod:
Salmonella: absence in 25g: n = 5, c = 0, m = 0, M = 0,
( 2 ) bodisi [je bil zapakiran v novih ali steriliziranih vrečah]
Enterobacteriaceae: n = 5, c = 2, m = 10, M = 300 in 1 gram;
( 2 ) ali [se je v razsutem stanju prevažal v kontejnerjih ali drugih prevoznih sredstvih, pred uporabo temeljito očiščenih in razkuženih z razkužilom, ki ga je odobril pristojni organ,]
the end product was:
ter je označen z nalepkami z navedbo „NI NAMENJENO ZA PREHRANO LJUDI“;
( 2 ) either [packed in new or sterilised bags;]
končni proizvod je bil skladiščen v zaprtem skladišču;
( 2 ) or [transported in bulk in containers or other means of transport that were thoroughly cleaned and disinfected with a disinfectant approved by the competent authority before use,]
so bili uvedeni vsi varnostni ukrepi za preprečitev onesnaženja proizvoda s patogeni po obdelavi;
and which bear labels indicating ‘NOT FOR HUMAN CONSUMPTION’;
( 2 ) in [v primeru krvnih proizvodov, vključno z razprševanjem posušeno krvjo in krvno plazmo prašičjega izvora, namenjenima za krmljenje prašičev, so bili skladiščeni v suhem skladišču pri sobni temperaturi vsaj 6 tednov;]
the end product was stored in enclosed storage;
ne vsebujejo in niso pridobljeni iz:
the product has undergone all precautions to avoid contamination with pathogenic agents after treatment;
( 2 ) bodisi [snovi s specifičnim tveganjem ali mehansko odstranjenega mesa s kosti goveda, ovc ali koz in da živali – razen živali, ki so bile rojene, neprekinjeno rejene in zaklane v državi ali regiji, ki je v skladu s členom 5(2) Uredbe (ES) št. 999/2001 Evropskega parlamenta in Sveta ( 5 ) opredeljena kot država ali regija z zanemarljivim tveganjem za BSE –, iz katerih je ta živalski stranski proizvod ali pridobljeni proizvod dobljen, niso bile zaklane po omamljanju z vbrizgavanjem plina v kranialno votlino ali pokončane po isti metodi ali zaklane z uničenjem centralnega živčnega tkiva z vstavljanjem podolgovatega paličastega instrumenta v kranialno votlino.]
( 2 ) and [in the case of blood products, including spray dried blood and blood plasma of porcine origin intended for the feeding of porcine animals, has been stored in dry warehouse conditions under room temperature for at least 6 weeks.]
( 2 ) ali [govejih, ovčjih in kozjih snovi, razen tistih, pridobljenih iz živali, ki so bile rojene, neprekinjeno rejene in zaklane v državi ali regiji, ki je v skladu s členom 5(2) Uredbe (ES) št. 999/2001 opredeljena kot država ali regija z zanemarljivim tveganjem za BSE.]
does not contain and is not derived from:
Del II: Certificiranje
( 2 ) either [specified risk material or mechanically separated meat obtained from bones of bovine, ovine or caprine animals and, except for animals born, continuously reared and slaughtered in a country or region classified as posing a negligible BSE risk by a decision in accordance with Article 5(2) of Regulation (EC) No 999/2001 of the European Parliament and of the Council ( 5 ), the animals from which this animal by-product or derived product is derived, have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration of central nervous tissue by means of an elongated rod- shaped instrument introduced into the cranial cavity.]
Opombe
( 2 ) or [bovine, ovine and caprine materials other than those derived from animals born, continuously reared and slaughtered in a country or region classified as posing a negligible BSE risk by a decision in accordance with Article 5(2) of Regulation (EC) No 999/2001.]
Del I:
Part II: Certification
Rubrika I.6.: oseba v EU, odgovorna za pošiljko: to rubriko izpolniti samo, če gre za spričevalo za blago v tranzitu; lahko se izpolni, če gre za spričevalo za uvozno blago.
Notes
Rubrika I.12: Namembni kraj: to rubriko izpolniti samo, če gre za spričevalo za blago v tranzitu.
Part I:
Proizvodi v tranzitu so lahko skladiščeni samo v prostocarinskih conah, prostih skladiščih in carinskih skladiščih.
Box reference I.6: Person responsible for the consignment in the European Union: this box is to be filled in only if it is a certificate for transit commodity; it may be filled in if the certificate is for import commodity.
Rubrika I.15: registrska številka (železniških vagonov ali kontejnerjev in tovornjakov), številka leta (letala) ali ime (ladje); podatke je treba predložiti v primeru razkladanja in ponovnega nakladanja.
Box reference I.12: Place of destination: this box is to be filled in only if it is a certificate for transit commodity.
Rubrika I.19: uporabiti ustrezno oznako HS: 05.11.91 ali 05.11.99.
The products in transit can only be stored in free zones, free warehouses and custom warehouses.
Rubrika I.23: za kontejnerje za razsuti tovor je treba prav tako navesti številko kontejnerja in številko zalivke (če je primerno).
Box reference I.15: Registration number (railway wagons or container and lorries), flight number (aircraft) or name (ship); information is to be provided in case of unloading and reloading.
Rubrika I.25: tehnična uporaba: katera koli uporaba, razen za prehrano živali.
Box reference I.19: use the appropriate HS code: 05.11.91 or 05.11.99.
Rubriki I.26 in I.27: izpolniti v skladu s tem, ali gre za spričevalo za tranzit ali uvoz.
Box reference I.23: for bulk containers, the container number and the seal number (if applicable) should be included.
Rubrika I.28: Vrsta: navedite eno od naslednjih možnosti: Aves, Ruminantia, Suidae, Mammalia razen Ruminantia, Pesca, Reptilia .
Box reference I.25: technical use: any use other than for animal consumption.
Del II:
Box reference I.26 and I.27: fill in according to whether it is a transit or an import certificate.
( 1a ) UL L 300, 14.11.2009, str.
Box reference I.28: Species: select from the following: Aves, Ruminantia, Suidae, Mammalia other than Ruminantia, Pesca, Reptilia.
1.
Part II:
( 1b ) UL L 54, 26.2.2011, str.
( 1a ) OJ L 300, 14.11.2009, p.
1.
1.
( 2 ) Neustrezno črtati.
( 1b ) OJ L 54, 26.2.2011, p.
( 3 ) Vpisati metodo od 1 do 5 ali 7, kar je ustrezno.
1.
( 4 ) Pri čemer:
( 2 ) Delete as appropriate.
n = število vzorcev, ki se testira;
( 3 ) Insert method 1 to 5 or 7 as applicable.
m = mejna vrednost števila bakterij; rezultati preiskav so ustrezni, če število bakterij v vseh vzorcih ne presega vrednosti m;
( 4 ) Where:
M = najvišja vrednost števila bakterij; rezultati preiskav so neustrezni, če je število bakterij v enem ali več vzorcih enako vrednosti M ali več; in
n = number of samples to be tested;
c = število vzorcev, pri katerih je število bakterij lahko med vrednostma m in M, vzorec pa še vedno velja za ustreznega, če je število bakterij v drugih vzorcih m ali manj.
m = threshold value for the number of bacteria; the result is considered satisfactory if the number of bacteria in all samples does not exceed m;
( 5 ) UL L 147, 31.5.2001, str.
c = number of samples the bacterial count of which may be between m and M, the sample still being considered acceptable if the bacterial count of the other samples is m or less.
Barva podpisa in žiga se mora razlikovati od barve tiska.
( 5 ) OJ L 147, 31.5.2001, p.
Opomba za osebo, odgovorno za pošiljko v EU: to spričevalo se izdaja le v veterinarske namene in mora spremljati pošiljko do mejne kontrolne točke.
1.
Uradni veterinar/uradni inšpektor
Commission Implementing Regulation (EU) No 484/2014
Izvedbena uredba Komisije (EU) št. 484/2014
laying down implementing technical standards with regard to the hypothetical capital of a central counterparty according to Regulation (EU) No 648/2012 of the European Parliament and of the Council
o določitvi izvedbenih tehničnih standardov glede hipotetičnega kapitala centralne nasprotne stranke v skladu z Uredbo (EU) št. 648/2012 Evropskega parlamenta in Sveta
Having regard to Regulation (EU) No 648/2012 of 4 July 2012 of the European Parliament and of the Council on OTC derivatives, central counterparties and trade repositories [1], and in particular the third subparagraph of Article 50a(4) and the third subparagraph of Article 50c(3) thereof,
ob upoštevanju Uredbe (EU) št. 648/2012 Evropskega parlamenta in Sveta z dne 4. julija 2012 o izvedenih finančnih instrumentih OTC, centralnih nasprotnih strankah in repozitorijih sklenjenih poslov [1] ter zlasti tretjega pododstavka člena 50a(4) in tretjega pododstavka člena 50c(3) Uredbe,
In accordance with Regulation (EU) No 575/2013 of the European Parliament and of the Council [2] institutions established in the Union are currently reporting their compliance with the own funds requirements on a quarterly basis.
V skladu z Uredbo (EU) št. 575/2013 Evropskega parlamenta in Sveta [2] institucije s sedežem v Uniji trenutno vsako četrtletje poročajo o izpolnjevanju obveznosti v zvezi s kapitalskimi zahtevami.
In order to minimise inconsistencies between the reference dates set for institutions and the dates set for central counterparties (CCPs) for the calculation and reporting of the information related to the hypothetical capital, the reference dates set for CCPs should cover at least the reference dates already set for institutions.
Da bi se v čim večji meri zmanjšale neskladnosti med referenčnimi datumi, določenimi za institucije, in datumi, določenimi za centralne nasprotne stranke (v nadaljnjem besedilu: CNS), za izračun in poročanje informacij, povezanih s hipotetičnim kapitalom, bi morali referenčni datumi, določeni za CNS, zajemati vsaj referenčne datume, ki so že določeni za institucije.
However, a higher frequency of reporting of the information related to the hypothetical capital would also accommodate the fact that clearing members established in third countries can have different reporting dates.
Vendar bi se pri večji pogostosti poročanja informacij v zvezi s hipotetičnim kapitalom moralo upoštevati tudi dejstvo, da imajo lahko klirinški člani s sedežem v tretjih državah drugačne datume poročanja.
Furthermore, there might be large variations in own funds requirements and for them to have an updated view of those requirements, clearing members and their competent authorities might want to monitor those exposures more frequently than quarterly.
Poleg tega lahko obstajajo velike razlike v kapitalskih zahtevah, in da bi imeli aktualen pregled nad navedenimi zahtevami, bodo klirinški člani in njihovi pristojni organi morda želeli navedene izpostavljenosti spremljati pogosteje kot vsako četrtletje.
In normal situations, the reporting dates for CCPs should not be delayed by more than one week with respect to the date of calculation.
V običajnih razmerah datumi poročanja za CNS ne bi smeli zaostajati več kot en teden za datumom izračuna.
A week provides CCPs with sufficient time in order to perform all the internal controls and complete the necessary approval process before reporting the required data.
En teden je dovolj časa za CNS, da izvede vse notranje kontrole ter zaključi potrebni proces odobritve, preden sporoči zahtevane podatke.
If a CCP develops a fully automated system the reporting date can be close to the calculation date.
Če CNS razvije popolnoma avtomatiziran sistem, je lahko datum poročanja zelo blizu datuma izračuna.
Currently, however, CCPs might not have the capability to complete the entire process within this time and might therefore need to develop their internal processes and infrastructures in order to be able to do so.
Vendar trenutno CNS morda nimajo zmogljivosti, da bi celoten postopek zaključile v tem času, in bodo morda morale razviti svoje notranje postopke in infrastrukture, da bodo to lahko storile.
Against this background, a transitional provision should be introduced to give CCPs sufficient time to develop the necessary internal processes and infrastructures and, at the same time, to start reporting the information related to the hypothetical capital to their clearing members.
Glede na to bi bilo treba uvesti prehodno določbo, da bi se CNS zagotovilo dovolj časa, da razvijejo potrebne notranje postopke in infrastrukture, pa tudi, da klirinškim članom začnejo poročati informacije v zvezi s hipotetičnim kapitalom.
Pursuant to Regulation (EU) No 648/2012 the losses following the default of a clearing member would, in the first instance, be covered by the initial margin and by the default fund contribution of the defaulting member itself.
V skladu z Uredbo (EU) št. 648/2012 bi se izgube v primeru neplačila klirinškega člana najprej krile z začetnim kritjem člana, ki je v zaostanku s plačili, in njegovim prispevkom v jamstveni sklad.
Where those prove to be insufficient, the losses are covered by the pre-funded financial resources that are contributed by CCPs to their respective default waterfalls and by the pre-funded default fund contributions of the non-defaulting members.
Če to ne zadošča, se izgube krijejo s predhodno financiranimi finančnimi viri, ki jih CNS prispevajo za potrebe kaskadnega kritja neplačila, in s predhodno financiranimi prispevki v jamstveni sklad članov, ki niso v zaostanku s plačili.
During this period, the frequency of reporting should be increased in order to keep the other non-defaulting clearing members and the competent authorities updated on all the information related to the hypothetical capital needed to calculate the clearing members' own fund requirements.
V tem obdobju bi bilo treba povečati pogostost poročanja, da bi drugi klirinški člani, ki niso v zaostanku s plačili, in pristojni organi imeli vse aktualne informacije v zvezi s hipotetičnim kapitalom, potrebnim za izračun kapitalskih zahtev klirinških članov.
CCPs should have the technical capabilities and the internal processes in place in order to compute and deliver the information related to the hypothetical capital under those stress situations.
CNS bi morale razpolagati s tehničnimi zmogljivostmi in notranjimi postopki za izračun in predložitev informacij, povezanih s hipotetičnim kapitalom v takih izjemnih razmerah.
Pursuant to Regulation (EU) No 648/2012, a CCP has to replenish its pre-funded own financial resources in the default waterfall within one month.
V skladu z Uredbo (EU) št. 648/2012 mora CNS v roku enega meseca obnoviti predhodno financirana lastna finančna sredstva za potrebe kaskadnega kritja neplačila.
For this reason, the frequencies of calculation and reporting in these situations should be higher than the norm.
V ta namen bi morala biti pogostost izračuna in poročanja v teh razmerah večja od običajne.
Daily reporting of the information related to hypothetical capital could be less meaningful because it might take time to establish the total size of the losses following the clearing member's default.
Dnevno poročanje informacij v zvezi s hipotetičnim kapitalom bi lahko bilo manj smiselno, saj lahko traja nekaj časa, da se ugotovi skupni obseg izgub v primeru neplačila klirinškega člana.
Given that they may face a broad range of different scenarios, competent authorities should also have the option to request a higher frequency in periods of stress based on an assessment of the situation that should take into account the degree of actual or foreseen depletion of the pre-funded financial resources available to the CCP (both those contributed by the CCP itself and those contributed by clearing members).
Glede na to, da se lahko soočijo z vrsto različnih scenarijev, bi morali pristojni organi imeti tudi možnost, da zahtevajo večjo pogostost poročanja v obdobjih izjemnih razmer na osnovi ocene razmer, pri katerih bi se morala upoštevati stopnja dejanskega ali predvidenega zmanjšanja predhodno financiranih finančnih sredstev, ki so na voljo CNS (tako tistih, ki jih je prispevala CNS, kot tistih, ki so jih prispevali klirinški člani).
The higher frequency should apply until those resources are restored to levels required by the relevant legislation.
Večja pogostost poročanja bi se morala uporabljati, dokler se navedeni viri ne obnovijo na raven, ki jo zahteva zadevna zakonodaja.
The high frequency of reporting in periods of stress can be very demanding given the newly introduced reporting requirement.
Velika pogostost poročanja v obdobjih izjemnih razmer je lahko zelo zahtevna zaradi na novo uvedene zahteve po poročanju.
This may pose challenges as regards the technical implementation for at least some CCPs.
To lahko predstavlja izzive v zvezi s tehnično izvedbo vsaj za nekatere CNS.
To mitigate this, it is appropriate to have a later date of application for the requirements of higher frequency of reporting.
Da bi se ti izzivi omilili, je ustrezno določiti kasnejši datum začetka uporabe za zahteve po večji pogostosti poročanja.
That will allow CCPs to improve their internal processes and upgrade their systems.
To bo CNS omogočilo, da izboljšajo notranje postopke in nadgradijo svoje sisteme.
The provisions in this Regulation are closely linked, since they deal with the calculation and reporting of the hypothetical capital of a CCP.
Določbe v tej uredbi so tesno medsebojno povezane, saj se nanašajo na izračun in poročanje hipotetičnega kapitala CNS.
To ensure coherence between those provisions, which should enter into force at the same time, and to facilitate a comprehensive view and compact access to them by persons subject to those obligations, it is desirable to include all the relevant implementing technical standards required by Regulation (EU) No 648/2012 in a single Regulation.
Za zagotovitev skladnosti med navedenimi določbami, ki bi morale začeti veljati hkrati, in za omogočanje celovitega pregleda nad določbami in enotnega dostopa do njih za osebe, za katere veljajo navedene obveznosti, je zaželeno, da se vsi zadevni izvedbeni tehnični standardi, ki se zahtevajo z Uredbo (EU) št. 648/2012, vključijo v eno uredbo.
This Regulation is based on the draft implementing technical standards submitted by the European Banking Authority to the Commission.
Ta uredba temelji na osnutkih izvedbenih tehničnih standardov, ki jih je Evropski bančni organ predložil Komisiji.
The European Banking Authority has conducted open public consultations on the draft implementing technical standards on which this Regulation is based, analysed the potential related costs and benefits and requested the opinion of the Banking Stakeholder Group established in accordance with Article 37 of Regulation (EU) No 1093/2010 of the European Parliament and of the Council [3],
Evropski bančni organ je opravil javna posvetovanja o osnutkih izvedbenih tehničnih standardov, na katerih temelji ta uredba, analiziral morebitne povezane stroške in koristi ter zaprosil za mnenje interesno skupino za bančništvo, ustanovljeno v skladu s členom 37 Uredbe (EU) št. 1093/2010 Evropskega parlamenta in Sveta [3] –
Frequency and dates of the calculation required by Article 50a(3) of Regulation (EU) No 648/2012
Pogostost in datumi izračuna, ki ga zahteva člen 50a(3) Uredbe (EU) št. 648/2012
The frequency of the calculation specified in Article 50a(3) of Regulation (EU) No 648/2012 shall be monthly except where the discretion provided for in Article 3(1) of this Regulation is exercised, in which case the frequency shall be either weekly or daily.
Izračun, določen v členu 50a(3) Uredbe (EU) št. 648/2012, se opravi mesečno, razen kadar se uveljavlja diskrecijska pravica iz člena 3(1) te uredbe, ko se izračun opravi tedensko ali dnevno.
Where the frequency of the calculation referred to in paragraph 1 is monthly, the CCP shall apply both of the following:
Če je pogostost izračuna iz odstavka 1 mesečna, CNS uporabi oboje od naslednjega:
the reference days for that calculation shall be as follows:
referenčni datumi izračuna so:
January 31, February 28 (or February 29 in a leap year), March 31, April 30, May 31, June 30, July 31, August 31, September 30, October 31, November 30, December 31;
31. januar, 28. februar (oziroma 29. februar v prestopnem letu), 31. marec, 30. april, 31. maj, 30. junij, 31. julij, 31. avgust, 30. september, 31. oktober, 30. november, 31. december;
the day on which the CCP shall undertake that calculation (day of calculation) shall be respectively:
datumi, na katere CNS opravijo izračun (v nadaljnjem besedilu: datum izračuna), so:
February 1, March 1, April 1, May 1, June 1, July 1, August 1, September 1, October 1, November 1, December 1, January 1.
1. februar, 1. marec, 1. april, 1. maj, 1. junij, 1. julij, 1. avgust, 1. september, 1. oktober, 1. november, 1. december, 1. januar.